Global Psoriasis Drugs Market Segmented by Type of Treatment, by Mechanism of Action, and by Route of Administration - Analysis, Growth, Trends & Forecast 2018-2023 - ResearchAndMarkets.com

DUBLIN--()--The "Global Psoriasis Drugs Market - Segmented by Type of Treatment, by Mechanism of Action, and by Route of Administration - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The psoriasis drugs market is expected to witness a CAGR of 9.3% during the forecast period. North America dominates the global market due to the high healthcare infrastructure, high adoption of therapeutics, and presence of major players in that region.

Biologic drugs that target specific proteins or cells are typically prescribed when other treatments have failed. Common side effects range from minor injection-site reactions to flu-like symptoms, to more serious respiratory infections. Biologic medication might also lead to an increased risk for infection or cancer of the lymph nodes (lymphoma), and they may also be associated with heart failure or central nervous system disorders. As a result of these side effects, these drugs are not prescribed for a long period of time. Many patients are also apprehensive to take drugs with potential adverse side effects, which is a major factor restraining the global psoriasis drugs market.

North America dominates the global market due to the high healthcare infrastructure, high adoption of therapeutics, and presence of major players in that region. Moreover, increasing prevalence and favorable government initiatives are some of the drivers that are responsible for the growth of the market.

Companies Mentioned

  • ELI LILLY
  • PFIZER INC.
  • JANSSEN BIOTECH Inc.
  • CELGENE CORPORATION
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • STIEFEL LABORATORIES INC.
  • NOVARTIS AG
  • AMGEN INC.
  • BIOGEN IDEC
  • ABBVIE INC.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/lh53k9/global_psoriasis?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs, Psoriasis Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs, Psoriasis Drugs